{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:49:47Z","timestamp":1791049787598,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1124\/dmd.108.024372","type":"journal-article","created":{"date-parts":[[2009,3,20]],"date-time":"2009-03-20T01:04:55Z","timestamp":1237511095000},"page":"1328-1333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ligand Diversity of Human and Chimpanzee CYP3A4: Activation of Human CYP3A4 by Lithocholic Acid Results from Positive Selection"],"prefix":"10.1016","volume":"37","author":[{"given":"Santosh","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Numan","family":"Oezguen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Herlyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Halpert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leszek","family":"Wojnowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.108.024372_bib1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev.pharmtox.45.120403.100004","article-title":"Non-Michaelis-Menten kinetics in cytochrome P450-catalyzed reactions","volume":"45","author":"Atkins","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.108.024372_bib2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bbalip.2004.11.003","article-title":"Novel pathways of bile acid metabolism involving CYP3A4","volume":"1687","author":"Bodin","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/dmd.108.024372_bib3","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1124\/jpet.108.141242","article-title":"Humanized mouse lines and their application for prediction of human drug metabolism and toxicological risk assessment","volume":"327","author":"Cheung","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.108.024372_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003088-200645010-00002","article-title":"Significance of the minor cytochrome P450 3A isoforms","volume":"45","author":"Daly","year":"2006","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.108.024372_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbrc.2003.09.247","article-title":"Conformational heterogeneity of cytochrome P450 3A4 revealed by high pressure spectroscopy","volume":"312","author":"Davydov","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.108.024372_bib6","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1124\/dmd.108.022194","article-title":"Identification of human hepatic cytochrome P450 enzymes involved in the biotransformation of cholic and chenodeoxycholic acid","volume":"36","author":"Deo","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.024372_bib7","doi-asserted-by":"crossref","first-page":"10150","DOI":"10.1021\/bi010758a","article-title":"Phenylalanine and tryptophan scanning mutagenesis of CYP3A4 substrate recognition site residues and effect on substrate oxidation and cooperativity","volume":"40","author":"Domanski","year":"2001","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.108.024372_bib8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.abb.2007.11.020","article-title":"Kinetics of electron transfer in the complex of cytochrome P450 3A4 with the flavin domain of cytochrome P450BM-3 as evidence of functional heterogeneity of the heme protein","volume":"471","author":"Fernando","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.108.024372_bib9","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.1074\/jbc.272.9.5396","article-title":"Alanine-scanning mutagenesis of a putative substrate recognition site in human cytochrome P450 3A4. Role of residues 210 and 211 in flavonoid activation and substrate specificity","volume":"272","author":"Harlow","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.108.024372_bib10","doi-asserted-by":"crossref","first-page":"8831","DOI":"10.1021\/bi970182i","article-title":"Identification of three key residues in substrate recognition site 5 of human cytochrome P450 3A4 by cassette and site-directed mutagenesis","volume":"36","author":"He","year":"1997","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.108.024372_bib11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0003-9861(02)00484-8","article-title":"Analysis of homotropic and heterotropic cooperativity of diazepam oxidation by CYP3A4 using site-directed mutagenesis and kinetic modeling","volume":"409","author":"He","year":"2003","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.108.024372_bib12","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1081\/DMR-200033475","article-title":"Detoxification of lithocholic acid, a toxic bile acid: relevance to drug hepatotoxicity","volume":"36","author":"Hofmann","year":"2004","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.108.024372_bib13","first-page":"1644","article-title":"Multisite kinetic models for CYP3A4: simultaneous activation and inhibition of diazepam and testosterone metabolism","volume":"29","author":"Kenworthy","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.024372_bib14","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1210\/me.2004-0427","article-title":"Evolution of the pregnane X receptor: adaptation to cross-species differences in biliary bile salts","volume":"19","author":"Krasowski","year":"2005","journal-title":"Mol Endocrinol"},{"key":"10.1124\/dmd.108.024372_bib15","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1124\/dmd.106.012054","article-title":"Engineering of cytochrome P450 3A4 for enhanced peroxide-mediated substrate oxidation using directed evolution and site-directed mutagenesis","volume":"34","author":"Kumar","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.024372_bib16","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1124\/mol.107.039693","article-title":"Rational engineering of human cytochrome P450 2B6 for enhanced expression and stability: importance of a Leu264\u2192 Phe substitution","volume":"72","author":"Kumar","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.108.024372_bib17","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0169-409X(02)00066-2","article-title":"Genetic contribution to variable human CYP3A-mediated metabolism","volume":"54","author":"Lamba","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/dmd.108.024372_bib18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev.nutr.27.061406.093659","article-title":"Effects of brain evolution on human nutrition and metabolism","volume":"27","author":"Leonard","year":"2007","journal-title":"Annu Rev Nutr"},{"key":"10.1124\/dmd.108.024372_bib19","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1126\/science.1070477","article-title":"Vitamin D receptor as an intestinal bile acid sensor","volume":"296","author":"Makishima","year":"2002","journal-title":"Science"},{"key":"10.1124\/dmd.108.024372_bib20","doi-asserted-by":"crossref","first-page":"21808","DOI":"10.1074\/jbc.M708582200","article-title":"Identification and analysis of conserved sequence motifs in cytochrome P450 family 2. Functional and structural role of a motif 187RFDYKD192 in CYP2B enzymes","volume":"283","author":"Oezguen","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.108.024372_bib21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00008571-200007000-00001","article-title":"Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method","volume":"10","author":"Ozdemir","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.108.024372_bib22","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1124\/dmd.105.008672","article-title":"The human intestinal cytochrome P450 \u201cpie.\u201d","volume":"34","author":"Paine","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.024372_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/FPC.0b013e3282f313f8","article-title":"CYP3 phylogenomics: evidence for positive selection of CYP3A4 and CYP3A7","volume":"18","author":"Qiu","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.108.024372_bib24","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0022-3565(25)22379-5","article-title":"Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians","volume":"270","author":"Shimada","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.108.024372_bib25","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1073\/pnas.051551698","article-title":"The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity","volume":"98","author":"Staudinger","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/dmd.108.024372_bib26","doi-asserted-by":"crossref","first-page":"11336","DOI":"10.1074\/jbc.M310258200","article-title":"Feed-forward regulation of bile acid detoxification by CYP3A4: studies in humanized transgenic mice","volume":"279","author":"Stedman","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.108.024372_bib27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1021\/bi061944p","article-title":"Mechanism of interactions of alpha-naphthoflavone with cytochrome P450 3A4 explored with an engineered enzyme bearing a fluorescent probe","volume":"46","author":"Tsalkova","year":"2007","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.108.024372_bib28","doi-asserted-by":"crossref","first-page":"12536","DOI":"10.1021\/bi980895g","article-title":"Structure-function relationships of human liver cytochromes P450 3A: aflatoxin B1 metabolism as a probe","volume":"37","author":"Wang","year":"1998","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.108.024372_bib29","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMra032424","article-title":"Drug metabolism and variability among patients in drug response","volume":"352","author":"Wilkinson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1124\/dmd.108.024372_bib30","doi-asserted-by":"crossref","first-page":"38091","DOI":"10.1074\/jbc.C400293200","article-title":"The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05-\u00c5 resolution","volume":"279","author":"Yano","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.108.024372_bib31","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/ng852","article-title":"Adaptive evolution of a duplicated pancreatic ribonuclease gene in a leaf-eating monkey","volume":"30","author":"Zhang","year":"2002","journal-title":"Nat Genet"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624020828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624020828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.108.024372","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:38:29Z","timestamp":1739896709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624020828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0090955624020828"],"URL":"https:\/\/doi.org\/10.1124\/dmd.108.024372","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ligand Diversity of Human and Chimpanzee CYP3A4: Activation of Human CYP3A4 by Lithocholic Acid Results from Positive Selection","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.108.024372","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2009 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}